Endovascular revascularisation versus conservative management for intermittent claudication

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 3, 2018, Pages

  Fakhry, Farzin ^a   Fokkenrood, Hugo J P ^b   Spronk, Sandra ^a,c   Teijink, Joep A W ^d   Rouwet, Ellen V ^a   Hunink, M G Myriam ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Department of Vascular Surgery ^*  (Netherlands)

^c Welfare and Sport   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONSERVATIVE TREATMENT; ENDOVASCULAR SURGERY; EVIDENCE BASED MEDICINE; HUMAN; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; PAIN; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; WALKING; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PROCEDURES; VASCULAR SURGERY;

CILOSTAZOL; TETRAZOLE DERIVATIVE; VASODILATOR AGENT;

COMBINED MODALITY THERAPY; CONSERVATIVE TREATMENT; EXERCISE THERAPY; HUMANS; INTERMITTENT CLAUDICATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TETRAZOLES; VASCULAR SURGICAL PROCEDURES; VASODILATOR AGENTS;

EID: 85043389124     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010512.pub2     Document Type: Review

References (68)

1. Creasy TS, McMillan PJ, Fletcher EW, Collin J, Morris PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European Journal of Vascular Surgery 1990;4(2):135-40. PUBMED: 2140987]
2. Perkins JM, Collin J, Creasy TS, Fletcher EW, Morris PJ. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. European Journal of Vascular and Endovascular Surgery 1996;11(4):409-13. PUBMED: 8846172]
3. Perkins JM, Collin J, Creasy TS, Fletcher EW, Morris PJ. Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". European Journal of Vascular and Endovascular Surgery 2011;42(Suppl 1): S41-5. PUBMED: 21855020]
4. Fakhry F. Randomized comparison of endovascular revascularization plus supervised exercise therapy versus supervised exercise therapy only in patients with peripheral artery disease and intermittent claudication: results of the endovascular revascularization and supervised exercise (ERASE) trial. Circulation 2013; Vol. 128, issue 24: 2709-10.
5. Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JA, Hoffmann WH, et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA 2015;314(18):1936-44. PUBMED: 26547465]
6. Greenhalgh RM, Belch JJ, Brown LC, Gaines PA, Gao L, Reise JA, et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular and Endovascular Surgery 2008;36(6):680-8.
7. Hobbs SD, Bradbury AW. The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. Journal of Vascular Surgery 2006; Vol. 44, issue 2:432-3. PUBMED: 16890883]
8. Hobbs SD, Marshall T, Fegan C, Adam DJ, Bradbury AW. The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. Journal of Vascular Surgery 2006;43(1):40-6. PUBMED: 16414385]
9. Lee HLD, Gulati S, Mehta T, Mekako AI, Rahman MNA, McCollum P, et al. Early result of a randomised controlled trial of treatment for intermittent claudication. The Vascular Society of Great Britain & Ireland Yearbook. 2007: 78.
10. Mazari FA, Gulati S, Rahman MN, Lee HL, Mehta TA, McCollum PT, et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Annals of Vascular Surgery 2010;24(1):69-79. PUBMED: 19762206]
11. Mazari FA, Khan JA, Carradice D, Samuel N, Abdul Rahman MN, Gulati S, et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery 2012;99(1):39-48. PUBMED: 22021102]
12. Mazari FA, Khan JA, Carradice D, Samuel N, Gohil R, McCollum PT, et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery 2013;100(9):1172-9. PUBMED: 23842831]
13. Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER 3rd, Cohen DJ, Reynolds MR, et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. Journal of the American College of Cardiology 2015;65(10): 999-1009. PUBMED: 25766947]
14. Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation 2012;125(1):130-9.
15. Murphy TP, Hirsch AT, Ricotta JJ, Cutlip DE, Mohler E, Regensteiner JG, et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. Journal of Vascular Surgery 2008;47(6): 1356-63.
16. Reynolds MR, Apruzzese P, Galper BZ, Murphy TP, Hirsch AT, Cutlip DE, et al. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. Journal of the American Heart Association 2014;3(6):e001233. PUBMED: 25389284]
17. Nordanstig J, Taft C, Hensater M, Perlander A, Osterberg K, Jivegard L. Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation 2014;130(12):939-47. PUBMED: 25095886]
18. Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum O, et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT) - the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery 2007;33(1):3-12. PUBMED: 17055756]
19. Nylaende M, Kroese AJ, Morken B, Stranden E, Sandbaek G, Lindahl AK, et al. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vascular Medicine (London, England) 2007;12(4):275-83. PUBMED: 18048463]
20. Fakhry F, Rouwet EV, den Hoed PT, Hunink MG, Spronk S. Long-term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. British Journal of Surgery 2013;100(9):1164-71. PUBMED: 23842830]
21. Fakhry F, Rouwet EV, den Hoed PT, Hunink MGM, Spronk S. Long-term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication: results from a randomized controlled trial. Circulation 2012;126(21 Suppl 1):Abstract 13102.
22. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial. Journal of Vascular Surgery 2008;48(6):1472-80. PUBMED: 18771879]
23. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training - randomized controlled trial. Radiology 2009;250(2):586-95. PUBMED: 19188327]
24. Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. Journal of Vascular Surgery 1997;26(4):551-7. PUBMED: 9357454]
25. Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. European Journal of Vascular and Endovascular Surgery 1996;12(2):167-72. PUBMED: 8760978]
26. Bo E, Hisdal J, Cvancarova M, Stranden E, Jorgensen JJ, Sandbaek G, et al. Twelve-months follow-up of supervised exercise after percutaneous transluminal angioplasty for intermittent claudication: a randomised clinical trial. International Journal of Environmental Research and Public Health 2013;10(11):5998-6014.
27. Brodmann M, Rief P, Froehlich H, Dorr A, Gary T, Eller P, et al. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial. Cardiovascular and Interventional Radiology 2013;36(1):69-74.
28. Gabrielli R, Rosati MS, Vitale S, Baciarello G, Siani A, Chiappa R, et al. Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions. Journal of Vascular Surgery 2012;56(6):1598-605.
29. Gelin J, Jivegard L, Taft C, Karlsson J, Sullivan M, Dahllof AG, et al. Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected randomised patients I: one year results of functional and physiological improvements. European Journal of Vascular and Endovascular Surgery 2001;22(2):107-13. PUBMED: 11472042]
30. Giugliano G, Di Serafino L, Perrino C, Schiano V, Laurenzano E, Cassese S, et al. Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease. International Journal of Cardiology 2013;167(6): 2566-71.
31. Heider P, Wildgruber M, Wolf O, Schuster T, Lutzenberger W, Berger H, et al. Improvement of microcirculation after percutaneous transluminal angioplasty in the lower limb with prostaglandin E1. Prostaglandins & Other Lipid Mediators 2009;88(1-2):23-30. PUBMED: 18832042]
32. Husmann M, Dorffler-Melly J, Kalka C, Diehm N, Baumgartner I, Silvestro A. Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease. Journal of Vascular Surgery 2008;48(5):1211-6.
33. Kruidenier LM, Nicolaï SP, Rouwet EV, Peters RJ, Prins MH, Teijink JAW. Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial. Journal of Vascular and Interventional Radiology 2011;22(7):961-8.
34. Thomson IA, van Rij AM, Morrison ND, Packer SGK, Christie R. A ten year randomised controlled trial of percutaneous femoropopliteal angioplasty for claudication. Australia and New Zealand Journal of Surgery 1999; Vol. 69, issue Suppl:98.
35. Frans FA, Bipat S, Reekers JA, Legemate DA, Koelemay MJW. SUPERvised exercise therapy or immediate PTA for intermittent claudication in patients with an iliac artery obstruction - a multicentre randomised controlled trial; SUPER study design and rationale. European Journal of Vascular and Endovascular Surgery 2012;43(4):466-71.
36. NCT01230229. Primary stenting vs conservative treatment in claudicants - a study on quality of life. www.clinicaltrials.gov/ct2/show/NCT01230229 (date first received 28 October 2010).
37. Ahimastos AA, Pappas EP, Buttner PG, Walker PJ, Kingwell BA, Golledge J. A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication. Journal of Vascular Surgery 2011; 54(5):1511-21. [PUBMED: 21958561]
38. Anderson PL, Gelijns A, Moskowitz A, Arons R, Gupta L, Weinberg A, et al. Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000. Journal of Vascular Surgery 2004;39(6):1200-8.
39. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. GRADEWorking Group. Grading quality of evidence and strength of recommendations. BMJ 2004; 328(7454):1490-4.
40. Beckman JA. Peripheral endovascular revascularization: some proof in the pudding?. Circulation 2007;115(5): 550-2.
41. Berger JS, Hiatt WR. Medical therapy in peripheral artery disease. Circulation 2012;126(4):491-500.
42. Bosch JL, van der Graaf Y, Hunink MG. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. The Dutch Iliac Stent Trial Study Group. Circulation 1999;99(24):3155-60.
43. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction: description of a new technic and a preliminary report of its application. Circulation 1964;30(5):654-70.
44. Fakhry F, van de Luijtgaarden KM, Bax L, den Hoed PT, Hunink MG, Rouwet EV, et al. Supervised walking therapy in patients with intermittent claudication. Journal of Vascular Surgery 2012;56(4):1132-42.
45. Fowkes FG, Gillespie IN. Angioplasty (versus non-surgical management) for intermittent claudication. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD000017
46. Frans FA, Bipat S, Reekers JA, Legemate DA, Koelemay MJ. Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication. British Journal of Surgery 2012;99(1):16-28. [PUBMED: 21928409]
47. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006;114(7):688-99.
48. Version accessed February 2017. Hamilton (ON): McMaster University (developed by Evidence Prime, Inc), 2015. GRADEpro Guideline Development Tool. Version accessed February 2017. Hamilton (ON): McMaster University (developed by Evidence Prime, Inc), 2015, Available from gradepro.org.
49. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. New England Journal of Medicine 2001; 344(21):1608-21.
50. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
51. Khaira HS, Hanger R, Shearman CP. Quality of life in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery 1996;11(1):65-9.
52. Makris GC, Lattimer CR, Lavida A, Geroulakos G. Availability of supervised exercise programs and the role of structured home-based exercise in peripheral arterial disease. European Journal of Vascular and Endovascular Surgery 2012; 44(6):569-75.
53. Matsi PJ, Manninen HI. Complications of lower-limb percutaneous transluminal angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovascular and Interventional Radiology 1998;21(5): 361-6.
54. Mazari FA, Khan JA, Carradice D, Samuel N, Abdul Rahman MN, Gulati S, et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery 2012;99(1):39-48.
55. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group. Inter-Society consensus for the management of peripheral arterial disease (TASC II). Journal of Vascular Surgery 2007;45 Suppl S: 5-67.
56. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
57. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA focused update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 2011;58(19): 2020-45.
58. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
59. Sieminski DJ, Gardner AW. The relationship between freeliving daily physical activity and the severity of peripheral arterial occlusive disease. Vascular Medicine 1997;2(4): 286-91.
60. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 1990;82(6):1925-31.
61. Sobieszczyk PS, Beckman JA. Intervention or exercise? The answer is yes!. Journal of the American College of Cardiology 2015; Vol. 65, issue 10:1010-2. [PUBMED: 25766948]
62. Spronk S, White JV, Bosch JL, Hunink MG. Impact of claudication and its treatment on quality of life. Seminars in Vascular Surgery 2007;20(1):3-9.
63. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training - randomized controlled trial. Radiology 2009;250(2):586-95.
64. Stewart KJ,Hiatt WR, Regensteiner JG,Hirsch AT. Exercise training for claudication. New England Journal of Medicine 2002;347(24):1941-51.
65. Tetteroo E, van der Graaf Y, Bosch JL, van Engelen AD, Hunink MG, Eikelboom BC, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet 1998;351(9110):1153-9.
66. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. Journal of Clinical Epidemiology 1992;45(5):529-42.
67. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD000990.pub2
68. Fakhry F, FokkenroodHJP, Rouwet EV, Teijink JAW, Spronk S, Hunink MGM. Endovascular revascularisation versus conservative management for intermittent claudication. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD010512